0.7901
price down icon10.05%   -0.0883
pre-market  시장 영업 전:  .80   0.0099   +1.25%
loading

Palisade Bio Inc 주식(PALI)의 최신 뉴스

pulisher
02:48 AM

How to monitor Palisade Bio Inc. with trend dashboardsReversal Signal Prediction Based on Volume - Newser

02:48 AM
pulisher
02:16 AM

Is Palisade Bio Inc. stock poised for growthFree Trade Scanner With Buy Zone Alerts - Newser

02:16 AM
pulisher
12:41 PM

Palisade Bio Inc. stock trendline breakdownNeural Model for Stock Price Movement - Newser

12:41 PM
pulisher
Aug 10, 2025

Palisade Bio's PDE4 Inhibitor PALI-2108 Achieves 100% Clinical Response Rate in Ulcerative Colitis Trial - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

Can you recover from losses in Palisade Bio Inc.Buy Alert Based on RSI and Volume - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

How Palisade Bio Inc. stock performs during market volatilityAlgorithmic Prediction of Market Breakouts - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Palisade Bio (PALI) to Release Earnings on Monday - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

What makes Palisade Bio Inc. stock price move sharplyDaily Profit Watch With Forecast Confidence - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Recovery Signals Appearing in Palisade Bio Inc. ChartsPotential Breakout Stock List Published This Week - beatles.ru

Aug 08, 2025
pulisher
Aug 07, 2025

Palisade Bio Soars on Breakthrough Ulcerative Colitis Data: What Investors Need to Know - RagingBull

Aug 07, 2025
pulisher
Aug 07, 2025

Is Palisade Bio Poised to Rise? - StocksToTrade

Aug 07, 2025
pulisher
Aug 07, 2025

Palisade Bio reports positive data for UC drug PALI-2108 By Investing.com - Investing.com Australia

Aug 07, 2025
pulisher
Aug 07, 2025

Palisade Bio Inc.’s Stock Climbs Amid Patent News: What’s Next? - timothysykes.com

Aug 07, 2025
pulisher
Aug 07, 2025

Palisade Bio Reports 100% Clinical Response in Phase 1b - GlobeNewswire

Aug 07, 2025
pulisher
Aug 07, 2025

Novel PDE4 Inhibitor Achieves 100% Response Rate in Phase 1b Ulcerative Colitis Trial | PALI Stock News - Stock Titan

Aug 07, 2025
pulisher
Aug 06, 2025

When is the best time to buy Palisade Bio Inc. stockShort-Term Trade Setup with Forecast Insight - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Institutional scanner results for Palisade Bio Inc.Real Time Screener for Growth Trades - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis - TipRanks

Aug 06, 2025
pulisher
Aug 05, 2025

Applying Elliott Wave Theory to Palisade Bio Inc.Free Low Drawdown Real Time Trading Tips - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Applying chart zones and confluence areas to Palisade Bio Inc.Free Weekly Top Gainers Forecast Watchlist - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Palisade Bio Inc. Builds Base for Possible ReboundLow Risk High Return Opportunities Identified - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Palisade Bio Inc. stockPowerful growth strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Palisade Bio Inc. stockBuild wealth steadily with proven investment techniques - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Palisade Bio Inc. compare to its industry peersIdentify winners with top-tier analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Palisade Bio Inc. a growth stock or a value stockMaximize your returns with smart trade entries - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Heatmap analysis for Palisade Bio Inc. and competitorsConservative Investment Setup and Risk Analysis - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Palisade Bio Inc. stock in 2025Skyrocketing investment returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Palisade Bio Inc. company’s key revenue driversMarket-crushing stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What institutional investors are buying Palisade Bio Inc. stockExceptional portfolio growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How does Palisade Bio Inc. generate profit in a changing economyGet daily updates on promising stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is Palisade Bio Inc. stock expected to show significant growthInvest confidently with expert support - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive Palisade Bio Inc. stock higher in 2025Free Capital Efficiency Planning - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How sentiment analysis helps forecast Palisade Bio Inc.Buy and Hold Position Summary Review - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

What is the risk reward ratio of investing in Palisade Bio Inc. stockTop Growth Review With High Returns - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Intraday pattern recognizer results for Palisade Bio Inc.Free Real Market Momentum Signal Generator - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Palisade Bio Receives Notice of Allowance for Composition - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

Palisade Bio secures patent allowance in China for PALI-2108 By Investing.com - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

Palisade Bio secures patent allowance in China for PALI-2108 - Investing.com

Jul 31, 2025
pulisher
Jul 31, 2025

Novel IBD Drug Gets 20-Year China Patent Protection: $1B Market Opportunity for First-in-Class Treatment - Stock Titan

Jul 31, 2025
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
자본화:     |  볼륨(24시간):